Suppr超能文献

临床实践中治疗性血液成分单采的使用指南——来自美国血液成分单采协会血液成分单采应用委员会的循证方法

Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.

作者信息

Szczepiorkowski Zbigniew M, Winters Jeffrey L, Bandarenko Nicholas, Kim Haewon C, Linenberger Michael L, Marques Marisa B, Sarode Ravindra, Schwartz Joseph, Weinstein Robert, Shaz Beth H

机构信息

Transfusion Medicine Service, Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA.

出版信息

J Clin Apher. 2010;25(3):83-177. doi: 10.1002/jca.20240.

Abstract

The American Society for Apheresis (ASFA) Apheresis Applications Committee is charged with a review and categorization of indications for therapeutic apheresis. Beginning with the 2007 ASFA Special Issue (fourth edition), the subcommittee has incorporated systematic review and evidence-based approach in the grading and categorization of indications. This Fifth ASFA Special Issue has further improved the process of using evidence-based medicine in the recommendations by refining the category definitions and by adding a grade of recommendation based on widely accepted GRADE system. The concept of a fact sheet was introduced in the Fourth edition and is only slightly modified in this current edition. The fact sheet succinctly summarizes the evidence for the use of therapeutic apheresis. The article consists of 59 fact sheets devoted to each disease entity currently categorized by the ASFA as category I through III. Category IV indications are also listed.

摘要

美国单采学会(ASFA)单采应用委员会负责对治疗性单采的适应证进行审查和分类。从2007年ASFA特刊(第四版)开始,该小组委员会在适应证的分级和分类中纳入了系统评价和循证方法。本第五版ASFA特刊通过完善类别定义并基于广泛接受的GRADE系统增加推荐等级,进一步改进了循证医学在推荐中的应用过程。情况说明书的概念在第四版中引入,在当前版本中仅略有修改。情况说明书简要总结了治疗性单采应用的证据。本文由59份情况说明书组成,分别针对目前被ASFA归类为I至III类的每个疾病实体。IV类适应证也有列出。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验